Work

Four-year results of a phase 2 study of the cathepsin K inhibitor odanacatib in postmenopausal women with low bone mineral density: Effects on bone mineral density and bone turnover markers

Year: 2011

Type: article

Source: Bone

DOI: 10.1016/j.bone.2011.03.129

Authors: H. Resch, N. Binkley, H. Bone, J. Eisman, D. Hosking, B. Langdahl, M. McClung, I. Reid, J. Rodriguez Portales, R. Petrovic, E. Rosenberg, C. DaSilva, A. Santora, A. Lombardi

Institutions: University of Wisconsin–Madison, Garvan Institute of Medical Research, St Vincent's Hospital Sydney, Nottingham City Hospital, Aarhus University Hospital, University of Auckland, Pontificia Universidad Católica de Chile, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Bone health and osteoporosis research

Subfield: Orthopedics and Sports Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2044858506

FWCI: 1.355

Cites:

Cited by: 4

Related to: 10